Human Longevity announces acquisition of Cypher Genomics

November 30, 2015

Human Longevity, Inc., the genomics-based, technology-driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions.

Previous Article
FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma
FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with...

Next Article
Medical professionals compare different treatment methods for Neuromyelitis optica
Medical professionals compare different treatment methods for Neuromyelitis optica

In the course of a study conducted throughout Germany, medical professionals have compared different treatm...